If you look at the chart of consolidated sales in the presentation slides, note that measured over 4 halves, sales growth is rather modest for a so-called growth stock.
The half year announcement is silent on a key metric - the number of tests sold. Why?
On the assumption that the $A stays high, my 2011 intrinsic value on this stock has fallen below $2.00. Sell?
Ann: Half Yearly Report and Accounts , page-5
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
